1. 107P Increasing responses to T-cell therapies in solid tumours by the use of an engineered adenovirus coding for TNFa and IL-2. (15th December 2019) Authors: Cervera-Carrascon, V; Havunen, R; Santos, J M; Quixabeira, D C A; Hemminki, A; Zafar, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 149P Revamping the ovarian tumour microenvironment with an oncolytic adenovirus yields enhanced tumour-infiltrating lymphocyte anti-tumour activity. (15th December 2019) Authors: Santos, J M; Heiniö, C; Cervera-Carrascon, V; Siurala, M; Quixabeira, D C A; de Gruijl, T; Lassus, H; Kanerva, A; Hemminki, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 43P Enhancing the therapeutic effect of dendritic cell therapy by oncolytic adenovirus 3 encoding CD40-ligand. (15th December 2019) Authors: Zafar, S; Quixabeira, D C A; Hemminki, O; Cervera-Carrascon, V; Santos, J M; Kanerva, A; Hemminki, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗